United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 125 mg - herpes labialis (cold sores): famciclovir tablets are indicated for the treatment of recurrent herpes labialis in adult patients. genital herpes: recurrent episodes: famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy: famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in adult patients. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles): famciclovir tablets are indicated for the treatment of herpes zoster in adult patients. the efficacy of famciclovir tablets when initiated more than 72 hours after onset of rash has not been established. recurrent orolabial or genital herpes: famciclovir tablets are indicated for the treatment of recurrent episodes of or

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 125 mg - herpes labialis (cold sores): famciclovir tablets are indicated for the treatment of recurrent herpes labialis in adult patients. genital herpes: recurrent episodes: famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy: famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in adult patients. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles): famciclovir tablets are indicated for the treatment of herpes zoster in adult patients. the efficacy of famciclovir tablets when initiated more than 72 hours after onset of rash has not been established.    recurrent orolabial or genital herpes: famciclovir tablets are indicated for the treatmen

United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 125 mg - herpes labialis (cold sores): famciclovir tablets are indicated for the treatment of recurrent herpes labialis in adult patients. genital herpes: recurrent episodes: famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy: famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes in adult patients. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles): famciclovir tablets are indicated for the treatment of herpes zoster in adult patients. the efficacy of famciclovir tablets when initiated more than 72 hours after onset of rash has not been established.    recurrent orolabial or genital herpes: famciclovir tablets are indicated for the treatmen

Australia - English - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - famciclovir -

Canada - English - Health Canada

pharmascience inc - famciclovir - tablet - 250mg - famciclovir 250mg - nucleosides and nucleotides

Canada - English - Health Canada

pharmascience inc - famciclovir - tablet - 500mg - famciclovir 500mg - nucleosides and nucleotides

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose; hyprolose; sodium starch glycollate; titanium dioxide; hypromellose; macrogol 6000; macrogol 4000 - famvir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of the rash. greatest benefit occurs if the drug is started within 48 hours. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster is generally a milder condition in younger patients. famvir is also indicated in the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. famvir is also indicated for suppression of recurrent genital herpes. famvir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent patients famvir is also indicated in immunocompromised patients for: treatment of uncomplicated herpes zoster; treatment of recurrent herpes simplex; suppression of recurrent herpes simplex

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -

United States - English - NLM (National Library of Medicine)

proficient rx lp - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 250 mg - herpes labialis (cold sores): famciclovir tablets are indicated for the treatment of recurrent herpes labialis. genital herpes: recurrent episodes: famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy: famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles): famciclovir tablets are indicated for the treatment of herpes zoster. the efficacy of famciclovir tablets when initiated more than 72 hours after onset of rash has not been established. recurrent orolabial or genital herpes: famciclovir tablets are indicated for the treatment of recurrent episodes of orolabial or genital herpes in hiv-infected adults. the e